ANAPTYSBIO, INC ANAB
ANAPTYSBIO, INC statistics & valuation
Market cap$1.8B
P / S7.8×
P / B49.4×
P / FCF93.7×
Net margin-5.6%
Return on equity-35.6%
FCF margin8.4%
Return on capital14.7%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | 20.4% | -125.9% | -958.3% | -1119.4% | -89.9% | -31.8% | -1342.9% | -1334.4% | -287.8% | -18.1% |
| Net margin | -5.6% | -159.1% | -953.7% | -1251.3% | -91.5% | -26.6% | -1216.7% | -1233.1% | -300.7% | -25.5% |
| FCF margin | 8.4% | -148.7% | -708.8% | -718.9% | -74.8% | -19.6% | -879.0% | -991.4% | -197.3% | -54.4% |
| Return on assets | -3.6% | -30.0% | -36.2% | -21.1% | -9.0% | -4.8% | -22.4% | -12.1% | -9.1% | -6.8% |
| Return on equity | -35.6% | -204.9% | -185.7% | -49.1% | -16.2% | -5.0% | -24.0% | -12.7% | -9.8% | 11.1% |
| Current ratio | 9.07 | 9.51 | 10.87 | 17.16 | 34.40 | 20.01 | 12.79 | 19.89 | 17.93 | 10.20 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.